Home The crystal structure of (3-chlorothiophene-2-carboxylato-κ2O, O′)-(2,2′-dipyridyl-κ2N,N′)lead(II), C20H12Cl2N2O4S2Pb
Article Open Access

The crystal structure of (3-chlorothiophene-2-carboxylato-κ2O, O′)-(2,2′-dipyridyl-κ2N,N′)lead(II), C20H12Cl2N2O4S2Pb

  • Zhongyu Zhang ORCID logo EMAIL logo , Chunhua Fu , Wan Sun and Chunmeng Dong
Published/Copyright: August 1, 2024
Download Article (PDF)
Become an author with De Gruyter Brill
Submit Manuscript Author Information
Zeitschrift für Kristallographie - New Crystal Structures
From the journal Zeitschrift für Kristallographie - New Crystal Structures Volume 239 Issue 5

Abstract

C20H12Cl2N2O4S2Pb, monoclinic, P21/c (no. 14), a = 13.2710(4) Å, b = 16.7810(4) Å, c = 9.6857(2) Å, β = 96.5550(1)°, V = 2142.91(9) Å3, Z = 4, R gt (F) = 0.0314, wR ref (F2) = 0.0807, T = 150.0 K.

CCDC no.: 2372851

The molecular structure is shown in the figure. Table 1 contains crystallographic data and Table 2 contains the list of the atoms including atomic coordinates and displacement parameters.

Table 1:

Data collection and handling.

Crystal: Yellow block
Size 0.20 × 0.20 × 0.20 mm
Wavelength:

μ:		 Mo Kα radiation (0.71073 Å)

8.35 mm−1
Diffractometer, scan mode:

θmax, completeness:		 Bruker APEX-II, φ and ω

26.4°, >99 %
N(hkl)measured, N(hkl)unique, Rint: 50608, 4394, 0.053
Criterion for Iobs, N(hkl)gt: Iobs > 2 σ(Iobs), 3762
N(param)refined: 280
Programs: Bruker, 1 Olex2 2
Table 2:

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

Atom x y z Uiso*/Ueq
Pb1 0.17230 (2) 0.56041 (2) 0.51915 (2) 0.03088 (8)
Cl1 0.33027 (12) 0.27700 (12) 0.7301 (3) 0.0793 (6)
Cl2 0.47136 (11) 0.66114 (10) 0.93610 (17) 0.0522 (4)
S1 0.01328 (11) 0.29835 (10) 0.72220 (17) 0.0509 (4)
S2 0.17355 (12) 0.66688 (10) 1.05059 (16) 0.0486 (4)
O1 0.0592 (3) 0.4360 (2) 0.5632 (4) 0.0406 (8)
O2 0.2269 (3) 0.4309 (2) 0.5924 (4) 0.0362 (8)
O3 0.1409 (3) 0.5887 (3) 0.7873 (4) 0.0539 (11)
O4 0.2984 (3) 0.5880 (2) 0.7293 (4) 0.0414 (8)
N1 0.1745 (3) 0.4958 (2) 0.2791 (4) 0.0338 (9)
N2 0.3416 (3) 0.5618 (2) 0.4164 (5) 0.0337 (9)
C1 0.1406 (4) 0.4015 (3) 0.6077 (5) 0.0322 (10)
C2 0.1335 (4) 0.3265 (3) 0.6851 (5) 0.0343 (10)
C3 0.2028 (4) 0.2733 (3) 0.7451 (6) 0.0438 (13)
C4 0.1622 (5) 0.2126 (3) 0.8223 (6) 0.0464 (13)
H4 0.201417 0.171859 0.870646 0.056*
C5 0.0614 (5) 0.2194 (4) 0.8193 (7) 0.0541 (15)
H5 0.021047 0.184004 0.866298 0.065*
C6 0.2332 (4) 0.6037 (3) 0.8113 (5) 0.0364 (11)
C7 0.2673 (4) 0.6444 (3) 0.9454 (5) 0.0379 (11)
C8 0.3586 (5) 0.6702 (3) 1.0070 (6) 0.0425 (12)
C9 0.3557 (5) 0.7075 (3) 1.1374 (6) 0.0485 (14)
H9 0.413280 0.728313 1.192903 0.058*
C10 0.2593 (5) 0.7094 (4) 1.1728 (6) 0.0529 (15)
H10 0.241753 0.732140 1.256658 0.063*
C11 0.0870 (4) 0.4697 (3) 0.2101 (6) 0.0407 (12)
H11 0.025804 0.476602 0.250868 0.049*
C12 0.0834 (5) 0.4331 (4) 0.0818 (6) 0.0487 (14)
H12 0.020910 0.414407 0.035509 0.058*
C13 0.1717 (5) 0.4242 (5) 0.0228 (6) 0.0548 (17)
H13 0.170762 0.399720 −0.065759 0.066*
C14 0.2628 (5) 0.4510 (4) 0.0926 (6) 0.0474 (14)
H14 0.324682 0.444037 0.053513 0.057*
C15 0.2617 (4) 0.4882 (3) 0.2203 (5) 0.0347 (11)
C16 0.3541 (4) 0.5233 (3) 0.2980 (5) 0.0336 (10)
C17 0.4482 (4) 0.5197 (3) 0.2491 (6) 0.0383 (11)
H17 0.455939 0.491201 0.166209 0.046*
C18 0.5308 (4) 0.5576 (3) 0.3206 (7) 0.0442 (13)
H18 0.595542 0.554944 0.287771 0.053*
C19 0.5182 (4) 0.5994 (3) 0.4400 (6) 0.0427 (13)
H19 0.572956 0.627277 0.490065 0.051*
C20 0.4217 (4) 0.5989 (3) 0.4843 (5) 0.0361 (11)
H20 0.412326 0.626589 0.567521 0.043*

1 Source of materials

3-Chlorothiophene-2-carboxylic acid (2.0 mmol) was dissolved in 20 mL of anhydrous methanol. Pb(CH3COO)2 (1.0 mmol) dissolved in 10 mL of anhydrous methanol was added dropwise to the above 3-chlorothiophene-2-carboxylic acid solution and stirred for 2 h at 50 °C. Then 2,2′-dipyridyl (1.0 mmol) was dissolved in 10 mL of anhydrous methanol and added dropwise to the above solution and stirred for 3 h at 50 °C cooled and filtered. The filtrate was left for slow evaporation at room temperature. The yellow block crystals were formed 14 days later. Yield: 41.7 %. Anal. Calcd. for C20H12Cl2N2O4S2Pb: C, 34.98; H, 1.76; N, 4.08; S, 9.34; found: C, 34.87; H, 1.72; N, 4.10; S, 9.33.

2 Experimental details

Hydrogen atoms were placed in their geometrically idealized positions and constrained to ride on parent atoms.

3 Comment

In the last decades, the application of metal complexes for the treatment of cancer were extensively explored and consequently, metal complexes were recognized as promising anticancer agents. 3 , 4 The chemical structures of thiophene and pyridine with heterocyclic compounds have antibacterial, anticancer and anti-inflammatory effects. 5 , 6 As a part of our current research interest on the biological activity of metal complexes, we report herein a new ternary lead metal complex constructed by 3-chlorothiophene-2-carboxylate and 2,2′-dipyridyl ligands. Single crystal X-ray diffraction analysis demonstrates that the asymmetric unit of the title structure contains one lead(II), two 3-chlorothiophene-2-carboxylate ligands and one 2,2′-dipyridyl ligand. The bond distances of Pb–N are 2.560(4) and 2.568 (4) Å, bond lengths of Pb–O are 2.374(3)−2.719(4) Å, respectively, which are similar with refs. 7 , 8 The Pb (II) is six coordinated by four oxygen and two nitrogen atoms from the 3-chlorothiophene-2-carboxylic acid ligands and one 2,2′-dipyridyl. There are two four-membered chelate rings (Pb–O(1)–C(1)–O(2), Pb(1)–O(3)–C(6)–O(4)) and one five-membered chelate ring (Pb–N(1)–C(15)–C(16)–N(2)). But the geometry of the complex is different from octahedron geometry, which forms an umbrella-like geometry in which Pb–O(2) bond serves as the umbrella handle. 9 , 10

Corresponding author: Zhongyu Zhang, College of Medicine and Nursing, Dezhou University, Dezhou, 253000, Shandong, China, E-mail:

Acknowledgments

This study was supported by the Transverse research project of Dezhou University (No. HXKT2022144 and No. HXKT2022212). the Bidding subject of Dezhou University (No. 2023XKZX010).

  1. Author contribution: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Competing interests: The authors declare no conflicts of interest regarding this article.

  3. Research funding: Transverse research project of Dezhou University (No. HXKT2022144 and No. HXKT2022212). the Bidding subject of Dezhou University (No. 2023XKZX010).

References

1. Bruker. APEX2, SAINT and SADABS; Bruker AXS Inc.: Madison,: Wisconsin, USA, 2004.Search in Google Scholar

2. Dolomanov, O. V.; Bourhis, L. J.; Gildea, R. J.; Howard, J. A. K.; Puschmann, H. OLEX2: a Complete Structure Solution, Refinement and Analysis Program. J. Appl. Crystallogr. 2009, 42, 339–341; https://doi.org/10.1107/s0021889808042726.Search in Google Scholar

3. Takasaki, S.; Takamizawa, S. Reversible Crystal Deformation of Asingle-Crystal Host of Copper (II) 1-Naphthoate-Pyrazine through Crystal Phase Transition Induced by Methanol Vapor Sorption. Chem. Commun. 2015, 51, 5024–5027; https://doi.org/10.1039/c4cc09948f.Search in Google Scholar PubMed

4. Yarnell, A.; Oh, S.; Reinberg, D.; Lippard, S. Interaction of FACT, SSRP1, and the High Mobility Group (HMG) Domain of SSRP1 with DNA Damaged by the Anticancer Drug Cisplatin. J. Biol. Chem. 2001, 276, 25736–25741; https://doi.org/10.1074/jbc.m101208200.Search in Google Scholar

5. Wei, M.; Peng, X.; Xing, L.; Dai, Y.; Huang, R.; Geng, M.; Zhang, A.; Ai, J.; Song, Z. Design, Synthesis and Biological Evaluation of a Series of Novel 2-Benzamide-4-(6-Oxy-n-Methyl-1-Naphthamide)-Pyridine Derivatives as Potent Fibroblast Growth Factor Receptor (fgfr) Inhibitors. Eur. J. Med. Chem. 2018, 154, 9–28; https://doi.org/10.1016/j.ejmech.2018.05.005.Search in Google Scholar PubMed

6. Ndagi, U.; Mhlongo, N.; Soliman, M. E. Metal Complexes in Cancer Therapy – an Update from Drug Design Perspective. Drug Des. Dev. Ther. 2017, 11, 599–616; https://doi.org/10.2147/dddt.s119488.Search in Google Scholar PubMed PubMed Central

7. Kowalik, M.; Masternak, J.; Kazimierczuk, K.; Kupcewicz, B.; Khavryuchenko, O. V.; Barszcz, B. Exploring Thiophene-2-Acetate and Thiophene-3-Acetate Binding Modes towards the Molecular and Supramolecular Structures and Photoluminescence Properties of Pb(II) Polymers. CrystEngComm 2020, 22, 7025–7035; https://doi.org/10.1039/d0ce01224f.Search in Google Scholar

8. Deng, Z.; Li, J.; Hou, X.; Luo, N.; Zhu, X. The Crystal Structure of di-μ-1-Naphthylacetato-κ3O,O′:O; κ3O:O,O′-bis[(1-Naphthylacetato-κ2O,O′)(2,2′-bipyridine-κ2N,N′)Lead(II)] Monohydrate, C68H54N4O9Pb2. Z. Kristallogr. N. Cryst. Struct. 2023, 238, 483–485; https://doi.org/10.1515/ncrs-2023-0045.Search in Google Scholar

9. Guo, F.; Su, C.; Fan, Y.; Fu, W. Two Pb(II) Coordination Complexes Based on 5-halonicotinate (Cl or Br): Structural Diversities and Sensing Performance. J. Solid State Chem. 2019, 277, 83–92; https://doi.org/10.1016/j.jssc.2019.05.044.Search in Google Scholar

10. Zhang, Z.; Bi, C.; Fan, Y.; Yan, X.; Zhang, P.; Huang, G. Synthesis, Crystal Structures, Luminescent Properties, Theoretical Calculation, and DNA Interaction of the Cadmium(II) and Lead(II) Complexes with o-Aminobenzoic Acid and 1,10-Phenanthroline1. Russ. J. Coord. Chem. 2015, 41, 274–284; https://doi.org/10.1134/s1070328415030094.Search in Google Scholar
Received: 2024-05-14
Accepted: 2024-07-23
Published Online: 2024-08-01
Published in Print: 2024-10-28

© 2024 the author(s), published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Frontmatter
  2. Editorial
  3. Editorial 2024 – New developments and changes of Zeitschrift für Kristallographie – New Crystal Structures
  4. New Crystal Structures
  5. Hydrogen bonding and π⋅⋅⋅halogen interactions in the crystal structure of bis(theophyllinium) hexachloridoplatinate(IV) monohydrate
  6. The crystal structure of 6-amino-2-carboxypyridin-1-ium perchlorate, C6H7ClN2O6
  7. Crystal structure of poly[(μ4-(3-amino-1H-1,2,4-triazol-1-yl)benzene-1,3-dicarboxylato-κ 4 N:O:O':O')(1-methylpyrroldin-2-one-κ1O)dicopper(II)] – 1-methylpyrroldin-2-one (1/3), C40H48Cu2N12O12
  8. The crystal structure of 18-crown-6-k6O6(2,4,5-trinitroimidazol-1-ido-k1O)potassium(I)
  9. Crystal structure of poly[tetraaqua-bis(μ2-5-bromoisophthalato-κ3O,O′:O″)-(μ2-1,5-bis(imidazol-2-methyl)pentane-κ2N:N′)dicadmium(II)] dihydrate
  10. Crystal structure of (5R,6S,E)-5-acetoxy-2-methyl-6-((2aR,3R,5aS,5bS,11aR,12aS)-2a,5a,8,8-tetramethyl-9-oxotetradecahydro-1H,12H-cyclopenta[a]cyclopropa[e]phenanthren-3-yl)hept-2-enoic acid, C32H48O5
  11. The crystal structure of poly[diaqua-bis(μ2 -thiocyanato-κ2N:O)cobalt(II) monohydrate
  12. The crystal structure of 1,3,5-tri(1H-imidazol-1-yl)benzene–2,3,5,6-tetrachlorobenzene-1,4-dicarboxylic acid (1/1)
  13. Crystal structure of dichlorido-bis(1-[(2-ethyl-benzimidazole-1-yl)methyl]-1H–benzotriazole) cadmium(II), C32H32CdN10OCl2
  14. The crystal structure of N′-(tert-butyl)-N′-(3,5-dimethylbenzoyl)-3-methoxy-N,2-dimethylbenzohydrazide, C23H30N2O3
  15. Crystal stucture of 3-benzamido-N-(2-bromo-4-(perfluoropropan-2-yl)-6-(trifluoromethyl)phenyl)-2-fluorobenzamide
  16. Crystal structure of bis(μ-benzeneselenolato)-(tetracarbonyl)-{μ-[N-(diphenylphosphanyl)-N-(3-ethynylphenyl)-P,P-diphenylphosphinous amide]} diiron, C48H35Fe2NO4P2Se2
  17. The crystal structure of 2′-(p-tolyl)-4′H-spiro[isochromane-1,1′-naphthalene]-3,4′-dione, C25H18O3
  18. The crystal structure of poly[hexaqua-tetrakis(μ4-pyridine-2,4-dicarboxylate-κ5N: O: O′: O″: O‴)-bi(μ2-pyridine-2,4-dicarboxylate-κ3N: O: O′)-digadolinium(III)tricopper (II)], [Gd2Cu3(C7H3NO4)6(H2O)6] n
  19. Crystal structure of poly[bis(4-(4-(pyridin-4-yl)phenyl)pyridin-1-ium-κ1N)-(μ4-benzene-1,2,4,5-tetracarboxylato-κ5O:O′: O″:O‴:O⁗)-(μ2-2,5-dicarboxyterephthalato-κ2O:O′)dizinc(II)], C52H32N4O16Zn2
  20. The crystal structure of 4-(3-carboxy-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinolin-7-yl)piperazin-1-ium 2-carboxy-6-nitrobenzoate monohydrate, C24H25FN4O10
  21. Crystal structure of dichlorido-(1-((3,5-dimethyl-2,3-dihydro-1H-1,2,3-triazol-1-yl)methyl)-1H-benzo[d][1,2,3]triazole-k1N)zinc(II), C22H24ZnN12Cl2
  22. The crystal structure of (3-chlorothiophene-2-carboxylato-κ2O, O′)-(2,2′-dipyridyl-κ2N,N′)lead(II), C20H12Cl2N2O4S2Pb
  23. Synthesis and crystal structure of (Z)-4-((1-(3-fluorophenyl)-1H-1,2,3-triazol-4-yl)methylene)-5-methyl-2-phenyl-2,4-dihydro-3H-pyrazol-3-one, C19H14FN5O
  24. The crystal structure of the coordination compound catena-poly[(18-crown-6-ether-κ6O6)(4,5-dinitroimidazolato-κ1O)potassium(I)]
  25. Crystal structure of 7-(diethylamino)-3-(trifluoroacetyl)-2H-chromen-2-one, C15H14F3NO3
  26. Crystal structure of dichlorido-1-[(2-ethylimidazole-1-yl)methyl]-1H–benzotriazole κ1N zinc(II), C24H26ZnN10Cl2
  27. Crystal and molecular structure of 5-bromopyridine-2,3-diamine
  28. Crystal structure of catena-poly[bis(μ2-1-(3-carboxyphenyl)-5-methyl-4-oxo-1,4-dihydropyridazine-3-carboxylato-k3-O,O′:O″)hexaqua-dicobalt tetrahydrate], C26H36N4O20Co2
  29. Crystal structure of thiocyanate-κ1N-bis(μ1-2,6-diformyl-4-methylphenol oxime-κ2N,O)-manganese(III) acetonitrile solvate, C21H21MnN6O6S
  30. The crystal structure of pyrrolidin-1-yl pivalate, C9H13NO4
  31. The crystal structure of 2,2′-(2,2-diphenylethene-1,1-diyl)bis(1,4-dimethoxybenzene), C30H28O4
  32. Crystal structure of bis(benzyltrimethylammonium) tetrathiotungstate(VI), {(C6H5CH2)(CH3)3N}2[WS4]
  33. The crystal structure of ethyl (Z)-2-(ethoxymethylene)-3-oxobutanoate, C9H14O4
  34. The crystal structure of (E)-6-bromo-3,5-dimethyl-2-(1-phenylprop-1-en-2-yl)-3Himidazo[4,5b]pyridine, C17H16BrN3
  35. Crystal structure of (3S,3′S,4R,4′S)-3′-(furan-3-yl)-3-hydroxy-4′-methyl-3,5,6′,7′-tetrahydro-1H,3′H-4,5′-spirobi[isobenzofuran]-1,1′(4′H)-dione-methanol (1/1), C21H22O7
  36. Cocrystal structure of progesterone-isophthalic acid, C25H33O4
  37. The crystal structure of 3-(6-fluoro-1H-indol-3-yl)-1-methylquinoxalin-2(1H)-one, C17H12FN3O
  38. Crystal structure of S-(4-carboxybutyl)- l -cysteine
  39. The cocrystal of 2,2′-(hydrazine-1,1-diyl)bis(1H-imidazole-4,5-dicarbonitrile)– methanol (2/3)
  40. Crystal structure of (1′R,2′S,4′R,6′S)-4,6-dihydroxy-1′,8′,8′-trimethyl-3-(3-methylbutanoyl)-4′,8′,6′,1′,7,2′-hexahydro-1H-4′,6′-methanoxanthene-8-carbaldehyde, C23H30O5
  41. Crystal structure of (3,6-di(2-pyridyl)-4-methylphenyl pyridazine-k 2 N,N′)-bis(1-phenyl-pyrazole-κ 2 C,N) iridium(III) hexafluorophosphate, C39H29F6IrN8P
  42. Crystal structure of 1,5-bis[(E)-1-(2-hydroxyphenyl)ethylidene]thiocarbonohydrazide dimethyl sulfoxide monosolvate, C17H18N4O2S·C2H6OS
  43. Crystal structure of (S)-4-(2-(4-(2-acetyl-5-chlorophenyl)-3-methoxy-6-oxopyridazin-1(6H)-yl)-3-phenylpropanamido)benzoic acid monohydrate, C29H26ClN3O7
  44. The crystal structure of 1,3-bis(2,4-dinitro-1H-imidazol-1-yl)propane
  45. Crystal structure of 4-chlorobenzyl (S)-2-(6-methoxynaphthalen-2-yl)propanoate, C21H19ClO3
  46. Crystal structure of 1-(5-(benzo[d][1,3]dioxol-5-yl)-4-benzyl-1-(4-bromophenyl)-4,5-dihydro-1H-1,2,4-triazol-3-yl)ethan-1-one, C24H20BrN3O3
  47. The crystal structure of (Z)-3′-(2-(1-(3,4-dimethyl-phenyl)-3-methyl-5-oxo-1,5-dihydro-4H-pyrazol-4-ylidene)hydrazinyl)-2′-hydroxy-[1,1′-biphenyl]-3-carboxylicacid ─ methanol (1/1), C26H26N4O5
  48. Crystal structure of (S)-1-phenylpropan-1-aminium (S)-(1-phenylpropyl)carbamate C19H26N2O2
  49. Synthesis and crystal structure of methyl 2-((5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl)thio)acetate, C18H16BrN3O2S
  50. The crystal structure of trichlorobis(pyridine-2,6-dithio-κS-carbomethylamido)antimony(III), [SbCl3(C9H11N3S2)2]
  51. Crystal structure of 1,8-dihydroxy-3-{[(triphenylstannyl)oxy]carbonyl} anthracene-9,10-dione, C33H22O6Sn
  52. The crystal structure of (E)-4-(2-(pyridin-4-ylmethylene)hydrazine-1-carbonyl)pyridin-1-ium-2-olate dihydrate, C12H14N4O4
  53. The crystal structure of 6-amino-pyridinium-2-carboxylate, C6H6N2O2
  54. The crystal structure of catena-poly[aqua-nitrato-κ3O,O:O′′-(1,10-phenanthroline-κ2N,N′)sodium(I)], C24H18N6O7Na2
  55. Retractions
  56. Retraction of: Crystal structure of bis[diaquaisonicotinatosamarium(III)]-µ-isonicotinato-[diisonicotinatocopper(II)], CuSm2(C6H4NO2)8(H2O)4
  57. Retraction of: Crystal structure of aqua(2,2′-bipyridine-k 2 N:N′)(nitrato)-(4-aminobenzoato)cadmium(II) nitrate, [Cd(H2O)(NO3)(C10H8N2)(C7H7NO2)][NO3]
https://doi.org/10.1515/ncrs-2024-0211
Creative Commons
BY 4.0

Articles in the same Issue

  1. Frontmatter
  2. Editorial
  3. Editorial 2024 – New developments and changes of Zeitschrift für Kristallographie – New Crystal Structures
  4. New Crystal Structures
  5. Hydrogen bonding and π⋅⋅⋅halogen interactions in the crystal structure of bis(theophyllinium) hexachloridoplatinate(IV) monohydrate
  6. The crystal structure of 6-amino-2-carboxypyridin-1-ium perchlorate, C6H7ClN2O6
  7. Crystal structure of poly[(μ4-(3-amino-1H-1,2,4-triazol-1-yl)benzene-1,3-dicarboxylato-κ 4 N:O:O':O')(1-methylpyrroldin-2-one-κ1O)dicopper(II)] – 1-methylpyrroldin-2-one (1/3), C40H48Cu2N12O12
  8. The crystal structure of 18-crown-6-k6O6(2,4,5-trinitroimidazol-1-ido-k1O)potassium(I)
  9. Crystal structure of poly[tetraaqua-bis(μ2-5-bromoisophthalato-κ3O,O′:O″)-(μ2-1,5-bis(imidazol-2-methyl)pentane-κ2N:N′)dicadmium(II)] dihydrate
  10. Crystal structure of (5R,6S,E)-5-acetoxy-2-methyl-6-((2aR,3R,5aS,5bS,11aR,12aS)-2a,5a,8,8-tetramethyl-9-oxotetradecahydro-1H,12H-cyclopenta[a]cyclopropa[e]phenanthren-3-yl)hept-2-enoic acid, C32H48O5
  11. The crystal structure of poly[diaqua-bis(μ2 -thiocyanato-κ2N:O)cobalt(II) monohydrate
  12. The crystal structure of 1,3,5-tri(1H-imidazol-1-yl)benzene–2,3,5,6-tetrachlorobenzene-1,4-dicarboxylic acid (1/1)
  13. Crystal structure of dichlorido-bis(1-[(2-ethyl-benzimidazole-1-yl)methyl]-1H–benzotriazole) cadmium(II), C32H32CdN10OCl2
  14. The crystal structure of N′-(tert-butyl)-N′-(3,5-dimethylbenzoyl)-3-methoxy-N,2-dimethylbenzohydrazide, C23H30N2O3
  15. Crystal stucture of 3-benzamido-N-(2-bromo-4-(perfluoropropan-2-yl)-6-(trifluoromethyl)phenyl)-2-fluorobenzamide
  16. Crystal structure of bis(μ-benzeneselenolato)-(tetracarbonyl)-{μ-[N-(diphenylphosphanyl)-N-(3-ethynylphenyl)-P,P-diphenylphosphinous amide]} diiron, C48H35Fe2NO4P2Se2
  17. The crystal structure of 2′-(p-tolyl)-4′H-spiro[isochromane-1,1′-naphthalene]-3,4′-dione, C25H18O3
  18. The crystal structure of poly[hexaqua-tetrakis(μ4-pyridine-2,4-dicarboxylate-κ5N: O: O′: O″: O‴)-bi(μ2-pyridine-2,4-dicarboxylate-κ3N: O: O′)-digadolinium(III)tricopper (II)], [Gd2Cu3(C7H3NO4)6(H2O)6] n
  19. Crystal structure of poly[bis(4-(4-(pyridin-4-yl)phenyl)pyridin-1-ium-κ1N)-(μ4-benzene-1,2,4,5-tetracarboxylato-κ5O:O′: O″:O‴:O⁗)-(μ2-2,5-dicarboxyterephthalato-κ2O:O′)dizinc(II)], C52H32N4O16Zn2
  20. The crystal structure of 4-(3-carboxy-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinolin-7-yl)piperazin-1-ium 2-carboxy-6-nitrobenzoate monohydrate, C24H25FN4O10
  21. Crystal structure of dichlorido-(1-((3,5-dimethyl-2,3-dihydro-1H-1,2,3-triazol-1-yl)methyl)-1H-benzo[d][1,2,3]triazole-k1N)zinc(II), C22H24ZnN12Cl2
  22. The crystal structure of (3-chlorothiophene-2-carboxylato-κ2O, O′)-(2,2′-dipyridyl-κ2N,N′)lead(II), C20H12Cl2N2O4S2Pb
  23. Synthesis and crystal structure of (Z)-4-((1-(3-fluorophenyl)-1H-1,2,3-triazol-4-yl)methylene)-5-methyl-2-phenyl-2,4-dihydro-3H-pyrazol-3-one, C19H14FN5O
  24. The crystal structure of the coordination compound catena-poly[(18-crown-6-ether-κ6O6)(4,5-dinitroimidazolato-κ1O)potassium(I)]
  25. Crystal structure of 7-(diethylamino)-3-(trifluoroacetyl)-2H-chromen-2-one, C15H14F3NO3
  26. Crystal structure of dichlorido-1-[(2-ethylimidazole-1-yl)methyl]-1H–benzotriazole κ1N zinc(II), C24H26ZnN10Cl2
  27. Crystal and molecular structure of 5-bromopyridine-2,3-diamine
  28. Crystal structure of catena-poly[bis(μ2-1-(3-carboxyphenyl)-5-methyl-4-oxo-1,4-dihydropyridazine-3-carboxylato-k3-O,O′:O″)hexaqua-dicobalt tetrahydrate], C26H36N4O20Co2
  29. Crystal structure of thiocyanate-κ1N-bis(μ1-2,6-diformyl-4-methylphenol oxime-κ2N,O)-manganese(III) acetonitrile solvate, C21H21MnN6O6S
  30. The crystal structure of pyrrolidin-1-yl pivalate, C9H13NO4
  31. The crystal structure of 2,2′-(2,2-diphenylethene-1,1-diyl)bis(1,4-dimethoxybenzene), C30H28O4
  32. Crystal structure of bis(benzyltrimethylammonium) tetrathiotungstate(VI), {(C6H5CH2)(CH3)3N}2[WS4]
  33. The crystal structure of ethyl (Z)-2-(ethoxymethylene)-3-oxobutanoate, C9H14O4
  34. The crystal structure of (E)-6-bromo-3,5-dimethyl-2-(1-phenylprop-1-en-2-yl)-3Himidazo[4,5b]pyridine, C17H16BrN3
  35. Crystal structure of (3S,3′S,4R,4′S)-3′-(furan-3-yl)-3-hydroxy-4′-methyl-3,5,6′,7′-tetrahydro-1H,3′H-4,5′-spirobi[isobenzofuran]-1,1′(4′H)-dione-methanol (1/1), C21H22O7
  36. Cocrystal structure of progesterone-isophthalic acid, C25H33O4
  37. The crystal structure of 3-(6-fluoro-1H-indol-3-yl)-1-methylquinoxalin-2(1H)-one, C17H12FN3O
  38. Crystal structure of S-(4-carboxybutyl)- l -cysteine
  39. The cocrystal of 2,2′-(hydrazine-1,1-diyl)bis(1H-imidazole-4,5-dicarbonitrile)– methanol (2/3)
  40. Crystal structure of (1′R,2′S,4′R,6′S)-4,6-dihydroxy-1′,8′,8′-trimethyl-3-(3-methylbutanoyl)-4′,8′,6′,1′,7,2′-hexahydro-1H-4′,6′-methanoxanthene-8-carbaldehyde, C23H30O5
  41. Crystal structure of (3,6-di(2-pyridyl)-4-methylphenyl pyridazine-k 2 N,N′)-bis(1-phenyl-pyrazole-κ 2 C,N) iridium(III) hexafluorophosphate, C39H29F6IrN8P
  42. Crystal structure of 1,5-bis[(E)-1-(2-hydroxyphenyl)ethylidene]thiocarbonohydrazide dimethyl sulfoxide monosolvate, C17H18N4O2S·C2H6OS
  43. Crystal structure of (S)-4-(2-(4-(2-acetyl-5-chlorophenyl)-3-methoxy-6-oxopyridazin-1(6H)-yl)-3-phenylpropanamido)benzoic acid monohydrate, C29H26ClN3O7
  44. The crystal structure of 1,3-bis(2,4-dinitro-1H-imidazol-1-yl)propane
  45. Crystal structure of 4-chlorobenzyl (S)-2-(6-methoxynaphthalen-2-yl)propanoate, C21H19ClO3
  46. Crystal structure of 1-(5-(benzo[d][1,3]dioxol-5-yl)-4-benzyl-1-(4-bromophenyl)-4,5-dihydro-1H-1,2,4-triazol-3-yl)ethan-1-one, C24H20BrN3O3
  47. The crystal structure of (Z)-3′-(2-(1-(3,4-dimethyl-phenyl)-3-methyl-5-oxo-1,5-dihydro-4H-pyrazol-4-ylidene)hydrazinyl)-2′-hydroxy-[1,1′-biphenyl]-3-carboxylicacid ─ methanol (1/1), C26H26N4O5
  48. Crystal structure of (S)-1-phenylpropan-1-aminium (S)-(1-phenylpropyl)carbamate C19H26N2O2
  49. Synthesis and crystal structure of methyl 2-((5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl)thio)acetate, C18H16BrN3O2S
  50. The crystal structure of trichlorobis(pyridine-2,6-dithio-κS-carbomethylamido)antimony(III), [SbCl3(C9H11N3S2)2]
  51. Crystal structure of 1,8-dihydroxy-3-{[(triphenylstannyl)oxy]carbonyl} anthracene-9,10-dione, C33H22O6Sn
  52. The crystal structure of (E)-4-(2-(pyridin-4-ylmethylene)hydrazine-1-carbonyl)pyridin-1-ium-2-olate dihydrate, C12H14N4O4
  53. The crystal structure of 6-amino-pyridinium-2-carboxylate, C6H6N2O2
  54. The crystal structure of catena-poly[aqua-nitrato-κ3O,O:O′′-(1,10-phenanthroline-κ2N,N′)sodium(I)], C24H18N6O7Na2
  55. Retractions
  56. Retraction of: Crystal structure of bis[diaquaisonicotinatosamarium(III)]-µ-isonicotinato-[diisonicotinatocopper(II)], CuSm2(C6H4NO2)8(H2O)4
  57. Retraction of: Crystal structure of aqua(2,2′-bipyridine-k 2 N:N′)(nitrato)-(4-aminobenzoato)cadmium(II) nitrate, [Cd(H2O)(NO3)(C10H8N2)(C7H7NO2)][NO3]
Sign up now to receive a 20% welcome discount
Institutional Access
How does access work?
Have an idea on how to improve our website?
Please write us.
© 2025 De Gruyter Brill
Downloaded on 28.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2024-0211/html
Scroll to top button